{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T20:45:08Z","timestamp":1777927508470,"version":"3.51.4"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2010,2,3]],"date-time":"2010-02-03T00:00:00Z","timestamp":1265155200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biometals"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1007\/s10534-010-9293-5","type":"journal-article","created":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T23:29:26Z","timestamp":1265066966000},"page":"185-196","source":"Crossref","is-referenced-by-count":41,"title":["HIV therapeutic possibilities of gold compounds"],"prefix":"10.1007","volume":"23","author":[{"given":"Pascaline N.","family":"Fonteh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frankline K.","family":"Keter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debra","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,2,3]]},"reference":[{"key":"9293_CR1","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.cct.2003.10.015","volume":"248","author":"S Ahmad","year":"2004","unstructured":"Ahmad S (2004) The chemistry of cyano complexes of gold (I) with emphasis on ligand scrambling reactions. Coord Chem Rev 248:231\u2013243","journal-title":"Coord Chem Rev"},{"key":"9293_CR2","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1016\/0006-2952(85)90341-7","volume":"34","author":"HS Allaudeen","year":"1985","unstructured":"Allaudeen HS, Snyder RM, Whitman MH, Crooke ST (1985) Effects of coordinated gold compounds on in vitro and in situ DNA replication. Biochem Pharmacol 34:3243\u20133250","journal-title":"Biochem Pharmacol"},{"key":"9293_CR3","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.jinorgbio.2007.11.003","volume":"102","author":"C Angela","year":"2008","unstructured":"Angela C, Christian H, Chiara G, Enrico M, Paul JD, Bernard KK, Luigi M (2008) Gold(III) compounds as anticancer agents: Relevance of gold\u2013protein interactions for their mechanism of action. J Inorg Biochem 102:564\u2013575 and references therein","journal-title":"J Inorg Biochem"},{"key":"9293_CR4","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1074\/jbc.274.3.1549","volume":"274","author":"EG Argyris","year":"1999","unstructured":"Argyris EG, Vanderkooi JM, Venkateswaran PS, Kay BK, Paterson Y (1999) The connection domain is implicated in metalloporphyrin binding and inhibition of HIV reverse transcriptase. J Biol Chem 274:1549\u20131556","journal-title":"J Biol Chem"},{"key":"9293_CR5","doi-asserted-by":"crossref","first-page":"5698","DOI":"10.1073\/pnas.96.10.5698","volume":"96","author":"M Baba","year":"1999","unstructured":"Baba M, Nishimura O, Kanzaki N, Okamoto M, Sawada H, Iizawa Y, Shiraishim M, Aramaki Y, Okonogi K, Ogawa Y, Meguro K, Fujino M (1999) A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity. Proc Natl Acad Sci USA 96:5698\u20135703","journal-title":"Proc Natl Acad Sci USA"},{"key":"9293_CR6","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/BF03214741","volume":"29","author":"SL Best","year":"1996","unstructured":"Best SL, Sadler PJ (1996) Gold drugs: mechanism of action and toxicity. Gold Bulletin 29:87\u201393","journal-title":"Gold Bulletin"},{"key":"9293_CR7","unstructured":"Blough H, Ricchetti M, Montagnier L, Buc H (1989) Organic gold compounds are effective against HIV-1 reverse transcriptase, vol 5. International conference on AIDS, Jun 4\u20139, p 559"},{"key":"9293_CR8","doi-asserted-by":"crossref","first-page":"6896","DOI":"10.1021\/ja710321g","volume":"130","author":"M Bowman","year":"2008","unstructured":"Bowman M, Ballard TE, Ackerson CJ, Feldheim DL, Margolis DM, Melander C (2008) Inhibition of HIV fusion with multivalent gold nanoparticles. J Am Chem Soc 130:6896\u20136897","journal-title":"J Am Chem Soc"},{"key":"9293_CR9","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.copbio.2007.01.006","volume":"18","author":"SD Caruthers","year":"2007","unstructured":"Caruthers SD, Wickline SA, Lanza GM (2007) Nanotechnological applications in medicine. Curr Opin Biotechnol 18:26\u201330","journal-title":"Curr Opin Biotechnol"},{"key":"9293_CR10","unstructured":"Che C-M (2004) Methods for using gold (III) complexes as anti-tumor and anti-HIV agents United States, patent: 2004, Pub No WO\/2004\/024146"},{"key":"9293_CR11","doi-asserted-by":"crossref","unstructured":"Che C-M, Sun RW-Y, Yu W-Y, Ko C-B, Zhu N, Sun H (2003) Gold(III) porphyrins as a new class of anticancer drugs: cytotoxicity, DNA binding and induction of apoptosis in human cervix epitheloid cancer cells. Chem Commun (14):1718\u20131719","DOI":"10.1039\/b303294a"},{"key":"9293_CR12","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1093\/rheumatology\/33.9.821","volume":"33","author":"A Crilly","year":"1994","unstructured":"Crilly A, Madhok R, Watson J, Capell HA, Sturrock RD (1994) Production of interleukin 6 by monocytes isolated from rheumatoid arthritis patients receiving second line drug therapy. Br J Rheumatol 33:821\u2013825","journal-title":"Br J Rheumatol"},{"key":"9293_CR13","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1002\/anr.1780321221","volume":"32","author":"LR Espinoza","year":"1989","unstructured":"Espinoza LR, Aguilar JL, Berman A, Gutierrez F, Vasey FB, Germain BF (1989) Rheumatic manifestations associated with human immunodeficiency virus infection. Arthritis Rhuem 32:1615\u20131622","journal-title":"Arthritis Rhuem"},{"key":"9293_CR14","doi-asserted-by":"crossref","unstructured":"Fonteh P, Meyer D (2009) Novel gold(I) phosphine compounds inhibit HIV-1 enzymes Metallomics 1:427\u2013433","DOI":"10.1039\/b909036c"},{"key":"9293_CR15","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.jinorgbio.2008.10.001","volume":"103","author":"PN Fonteh","year":"2009","unstructured":"Fonteh PN, Keter FK, Guzei I, Darkwa J, Meyer D (2009) Tetra-chloro-(bis-3, 5-dimethylpyraxol)methane)gold(III)chloride: an HIV-1 reverse transcriptase and protease inhibitor. J Inorg Biochem 103:190\u2013194","journal-title":"J Inorg Biochem"},{"issue":"2","key":"9293_CR16","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/BF03215464","volume":"29","author":"SP Fricker","year":"1996","unstructured":"Fricker SP (1996a) Medical uses of gold compounds: past, present and future. Gold Bulletin 29(2):53\u201359","journal-title":"Gold Bulletin"},{"key":"9293_CR17","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/BF00139037","volume":"21","author":"SP Fricker","year":"1996","unstructured":"Fricker SP (1996b) Medicinal chemistry and pharmacology of gold compounds. Trans Metal Chem 21:377\u2013383","journal-title":"Trans Metal Chem"},{"key":"9293_CR18","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0162-0134(88)80014-X","volume":"32","author":"EJ Gibbs","year":"1988","unstructured":"Gibbs EJ, Maurer MC, Zhang JH, Reiff WM, Hill DT, Malicka-Blaszkiewicz M, McKinnie ER, Liu H-Q, Pasternack RF (1988) Interactions of porphyrins with DNA and more highly organised structures. J Inorg Biochem 32:39\u201365","journal-title":"J Inorg Biochem"},{"issue":"1","key":"9293_CR19","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/BF03214805","volume":"34","author":"Z Huaizhi","year":"2001","unstructured":"Huaizhi Z, Yuantao N (2001) China\u2019s ancient gold drugs. Gold Bulletin 34(1):24\u201329","journal-title":"Gold Bulletin"},{"key":"9293_CR20","doi-asserted-by":"crossref","unstructured":"Keter FK, Ojwach SO, Oyetunji OA, Guzei IA, Darkwa J (2008) Bis(pyrazolyl)palladium(II), platinum(II) and gold(III) complexes: synthesis, molecular structures and reaction kinetics with l-Cysteine. Inorg Chim Acta 362:2595\u20132602","DOI":"10.1016\/j.ica.2008.11.030"},{"key":"9293_CR21","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1056\/NEJM199610313351803","volume":"335","author":"JA Kovacs","year":"1995","unstructured":"Kovacs JA, Baseler M, Dewar RJ, Vogel S, Davey RT, Falloon J, Polis MA, Walker RE, Stevens R, Salzman NP, Metcalf JA, Masur H, Lane HC (1995) Controlled trial of interleukin-2 infusions in patients infected with the human immunodeficiency virus. N Eng J Med 335:1350\u20131356","journal-title":"N Eng J Med"},{"key":"9293_CR22","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1007\/BF02004707","volume":"11","author":"JH Leibfarth","year":"1981","unstructured":"Leibfarth JH, Persellin RH (1981) Mechanism of action of gold. Agents and Actions 11:458\u2013472","journal-title":"Agents and Actions"},{"key":"9293_CR23","unstructured":"Liu H-Q, Cheung T-C, Peng S-M, Che, C-M (1995) Novel luminescent cyclometalated and terpyridine gold(III) complexes and DNA binding studies. J Chem Soc Chem Commun 1787\u20131788"},{"key":"9293_CR24","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/1043-4666(94)90038-8","volume":"6","author":"P Loetscher","year":"1994","unstructured":"Loetscher P, Dewald B, Baggiolini M, Seitz M (1994) Monocyte chemottractant protein 1 and interleukin 8 production by rheumatoid synoviocytes. Effects of anti-rheumatic drugs. Cytokine 6:162\u2013170","journal-title":"Cytokine"},{"key":"9293_CR25","first-page":"630","volume":"20","author":"R Madhok","year":"1993","unstructured":"Madhok R, Crilly A, Murphy E, Smith J, Watson J, Capell HA (1993) Gold therapy lowers serum interleukin levels in rheumatoid arthritis. J Rheumatol 20:630\u2013633","journal-title":"J Rheumatol"},{"key":"9293_CR26","first-page":"1818","volume":"23","author":"B Mascarenhas","year":"1972","unstructured":"Mascarenhas B, Granda J, Freyberg R (1972) Gold metabolism in patients with rheumatoid arthritis treated with gold compounds-reinvestigated. J Rheumatol 23:1818\u20131820","journal-title":"J Rheumatol"},{"key":"9293_CR27","unstructured":"Miller S (2002) Beyond the CD4 count. The clinician\u2019s guide to the immunity of HIV infection. Beckman Coulter 3(7):19\u201323, 27"},{"key":"9293_CR28","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1016\/j.ccr.2008.12.003","volume":"253","author":"M Navarro","year":"2009","unstructured":"Navarro M (2009) Gold complexes as potential anti-parasitic agents. Coord Chem Rev 253:1619\u20131625","journal-title":"Coord Chem Rev"},{"key":"9293_CR29","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1021\/jm9607358","volume":"40","author":"M Navarro","year":"1997","unstructured":"Navarro M, Perez H, Sanchez-Delgado GA, Schmidbaur H (1997) Toward a novel metal-based chemotherapy against tropical diseases. 3. Synthesis and Antimalarial Activity in vitro and in vivo of the New Gold-Chloroquine Complex (Au(PPh3)(CQ))PF6. J Med Chem 40:1937\u20131939","journal-title":"J Med Chem"},{"key":"9293_CR30","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1006\/viro.1993.1079","volume":"192","author":"T Okada","year":"1993","unstructured":"Okada T, Patterson BK, Ye S, Gurney ME (1993) Aurothiolates inhibit HIV-1 infectivity by gold (I) ligand exchange with a component of the virion surface. Virology 192:631\u2013642","journal-title":"Virology"},{"key":"9293_CR31","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199803263381301","volume":"338","author":"FJ Pallela","year":"1998","unstructured":"Pallela FJ, Delaney KM, Moorman AC, Loveless MM, Fuhrer J, Satten GA, Aschman DJ, Holmberg SD (1998) Declining morbidity and mortality among patients with advance human Immunodeficiency virus infection. HIV outpatient study investigations. N Engl J Med 338:853\u2013860","journal-title":"N Engl J Med"},{"issue":"1\/2","key":"9293_CR32","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/BF03214653","volume":"20","author":"RV Parish","year":"1987","unstructured":"Parish RV, Cottrill SM (1987) Medicinal gold compounds. Gold bulletin 20(1\/2):3\u201311","journal-title":"Gold bulletin"},{"issue":"4","key":"9293_CR33","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1351\/pac199870040863","volume":"70","author":"PJ Sadler","year":"1998","unstructured":"Sadler PJ, Guo Z (1998) Metal complexes in medicine: design and mechanism of action. Pure Appl Chem 70(4):863\u2013871","journal-title":"Pure Appl Chem"},{"key":"9293_CR34","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0010-8545(99)00018-1","volume":"185\u2013186","author":"PJ Sadler","year":"1999","unstructured":"Sadler PJ, Li H, Sun H (1999) Coordination chemistry of metals in medicine: target sites for bismuth. Coord Chem Rev 185\u2013186:689\u2013709","journal-title":"Coord Chem Rev"},{"key":"9293_CR35","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.virol.2006.05.016","volume":"352","author":"D Safarian","year":"2006","unstructured":"Safarian D, Carnec X, Tsamis F, Kajumo F, Dragic T (2006) An anti-CCR5 monoclonal antibody and small molecule CCR5 antagonists synergize by inhibiting different stages of human immunodeficiency virus type 1 entry. Virology 352:477\u2013484","journal-title":"Virology"},{"key":"9293_CR36","doi-asserted-by":"crossref","unstructured":"Saqqioro D, Rigobello MP, Paloschi L, Folda A, Moqqach SA, Parsons S, Ronconi L, Fregona D, Bindoli A (2007) Gold(III)-dithiocarbamato complexes induce cancer cell death triggered by thioredoxin redox system inhibition and activation of ERK pathway. Chem Biol 14:1128\u20131139 (references therein)","DOI":"10.1016\/j.chembiol.2007.08.016"},{"key":"9293_CR37","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/BF00274936","volume":"12","author":"M Seitz","year":"1992","unstructured":"Seitz M, Dewald B, Ceska M, Gerber N, Baggiolini M (1992) Interleukin-8 in inflammatory rheumatic diseases : synovial fluid levels, relation to rheumatoid factors, production by mononuclear cells, and effects of gold sodium thiomalate and methotrexate. Rheumatol Int 12:159\u2013164","journal-title":"Rheumatol Int"},{"key":"9293_CR38","first-page":"1818","volume":"23","author":"DL Shapiro","year":"1996","unstructured":"Shapiro DL, Masci JR (1996) Treatment of HIV associated psoriatic arthritis with oral gold. J Rheumatol 23:1818\u20131820","journal-title":"J Rheumatol"},{"key":"9293_CR39","first-page":"287","volume":"2","author":"CF Shaw III","year":"1979","unstructured":"Shaw CF III (1979) The mammalian biochemistry of gold: an inorganic perspective of chrysotherapy. Inorg Perspect Biol Med 2:287\u2013355","journal-title":"Inorg Perspect Biol Med"},{"key":"9293_CR40","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1021\/cr980431o","volume":"99","author":"CF Shaw III","year":"1999","unstructured":"Shaw CF III (1999) Gold-based therapeutic agents. Chem Rev 99:2589\u20132600","journal-title":"Chem Rev"},{"key":"9293_CR41","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.tiv.2004.11.001","volume":"19","author":"I Stern","year":"2005","unstructured":"Stern I, Wataha JC, Lewis JB, Messer RLW, Lockwood PE, Tseng WY (2005) Anti-rheumatic gold compounds as sublethal modulators of monocytic LPS-induced cytokine secretion. Toxicol In Vitro 19:365\u2013371","journal-title":"Toxicol In Vitro"},{"key":"9293_CR42","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1056\/NEJMra020542","volume":"347","author":"S Suerbaum","year":"2002","unstructured":"Suerbaum S, Michetti PN (2002) Helicobacter pylori infection. N Engl J Med 347:1175\u20131186","journal-title":"N Engl J Med"},{"key":"9293_CR43","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1002\/cbic.200300773","volume":"5","author":"RW-Y Sun","year":"2004","unstructured":"Sun RW-Y, Sun H, Che C-M (2004) In vitro inhibition of human immunodeficiency virus type-1 (HIV-1) reverse transcriptase by gold(III) porphyrins. Chem Bio Chem 5:1293\u20131298","journal-title":"Chem Bio Chem"},{"key":"9293_CR44","doi-asserted-by":"crossref","first-page":"4884","DOI":"10.1039\/b705079h","volume":"43","author":"RW-Y Sun","year":"2007","unstructured":"Sun RW-Y, Ma D-L, Wong EL-M, Che C-M (2007) Some uses of transition metal complexes as anti-cancer and anti-HIV agents. Dalton Trans 43:4884\u20134892","journal-title":"Dalton Trans"},{"issue":"1","key":"9293_CR45","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/BF03214639","volume":"19","author":"BM Sutton","year":"1986","unstructured":"Sutton BM (1986) Gold compounds for rheumatoid arthritis. Gold Bulletin 19(1):15\u201316","journal-title":"Gold Bulletin"},{"issue":"5\u20136","key":"9293_CR46","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1155\/MBD.1994.433","volume":"1","author":"K Tepperman","year":"1994","unstructured":"Tepperman K, Zhang Y, Roy PW, Floyd R, Zhao Z, Dorsey JG, Elder RC (1994) Transport of the diacyanogold (I) anion. Met Based Drugs 1(5\u20136):433\u2013443","journal-title":"Met Based Drugs"},{"issue":"2","key":"9293_CR47","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1093\/intimm\/11.2.143","volume":"1","author":"KE Traber","year":"1999","unstructured":"Traber KE, Okamoto H, Kurono C, Baba M, Saliou C, Soji T, Parker L, Okamoto T (1999) Anti-rheumatoid compound aurothioglucose inhibits tumour necrosis-\u03b1-induced HIV-1 replication in latently infected OM10.1 and Ach2 cells. Int Immunol 1(2):143\u2013150","journal-title":"Int Immunol"},{"key":"9293_CR48","first-page":"121","volume":"11","author":"A Wanchu","year":"2003","unstructured":"Wanchu A (2003) HIV infection: rheumatic manifestation. J Indian Rheumatol Assoc 11:121\u2013130","journal-title":"J Indian Rheumatol Assoc"},{"key":"9293_CR49","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nature01470","volume":"422","author":"X Wei","year":"2003","unstructured":"Wei X, Decker JM, Wang S, Hui H, Kappes JC, Xiaoyun WX, Salaza-Gonzalez JF, Salazar MG, Kilby JM, Saag MS, Komarova NL, Nowak MA, Hahn BH, Kwong PD, Shaw GM (2003) Antibody neutralization and escaby by HIV-1. Nature 422:307\u2013312","journal-title":"Nature"},{"key":"9293_CR50","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1348-0421.2001.tb02657.x","volume":"45","author":"K Yamaguchi","year":"2001","unstructured":"Yamaguchi K, Ushijima H, Hisano M, Inoue Y, Shimamura T, Hirano T, Muller WEG (2001) Immunodeficiency effect of gold sodium thiomalate on murine acquired immunodeficiency syndrome. Microbiol Immunol 45:549\u2013555","journal-title":"Microbiol Immunol"},{"key":"9293_CR51","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0014-5793(95)00157-5","volume":"361","author":"JP Yang","year":"1995","unstructured":"Yang JP, Merin JP, Nakano T, Kato T, Kitade S, Okamoto T (1995) Inhibition of the DNA-binding activity of NF-kappa B by gold compounds in vitro. FEBS Letters 361:89\u201396","journal-title":"FEBS Letters"},{"key":"9293_CR52","doi-asserted-by":"crossref","unstructured":"Yanni G, Nabil M, Farahat MR, Poston RN, Panayi GS (1994) Intramuscular gold decreases cytokine expression and macrophage numbers in the rehumatoid synovial membrane. Ann Rheum Dis 53:315\u2013322","DOI":"10.1136\/ard.53.5.315"},{"key":"9293_CR53","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1093\/intimm\/11.2.151","volume":"11","author":"S Yoshida","year":"1998","unstructured":"Yoshida S, Kato T, Sakurada S, Kurono C, Yang JP, Matsui N, Soji T, Okamoto T (1998) Inhibition of IL-6 and IL-8 induction from cultured rheumatoid synovial fibroblasts by treatment with aurothioglucose. Int Immunol 11:151\u2013158","journal-title":"Int Immunol"},{"key":"9293_CR54","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0020-1693(94)04254-S","volume":"229","author":"Y Zhang","year":"1995","unstructured":"Zhang Y, Hess EV, Pryhuber KG, Dorsey JG, Tepperman K, Elder RC (1995) Gold binding sites in red blood cells. Inorg Chim Acta 229:271\u2013280","journal-title":"Inorg Chim Acta"}],"container-title":["BioMetals"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10534-010-9293-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10534-010-9293-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10534-010-9293-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T12:11:35Z","timestamp":1559218295000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10534-010-9293-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2,3]]},"references-count":54,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["9293"],"URL":"https:\/\/doi.org\/10.1007\/s10534-010-9293-5","relation":{},"ISSN":["0966-0844","1572-8773"],"issn-type":[{"value":"0966-0844","type":"print"},{"value":"1572-8773","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,2,3]]}}}